The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection.
The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection.